| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PRKA | Common Stock, par value $0.001 per share | Purchase | $235,875 | +673,928 | +2.2% | $0.3500 | 31,128,633 | 14 Feb 2025 | See Footnote | F1 |
| transaction | PRKA | Common Stock, par value $0.001 per share | Purchase | $67,755 | +193,586 | +0.62% | $0.3500 | 31,322,219 | 14 Feb 2025 | See Footnote | F1 |
| Id | Content |
|---|---|
| F1 | The reported 31,322,219 shares of PRKA (the "Shares") are held by Focused Compounding Fund, LP, a Delaware limited partnership ("Focused Compounding Fund"). Focused Compounding Capital Management, LLC, a Delaware limited liability company ("Focused Compounding Capital"), is the general partner of Focused Compounding Fund. Each of Geoff Gannon ("Gannon") and Andrew Kuhn ("Kuhn") serves as a managing member of Focused Compounding Capital. Accordingly, each of Focused Compounding Capital, Gannon and Kuhn could be deemed an indirect beneficial owner of such Shares owned by Focused Compounding Fund. |